Return
Enhancing antitumor immunotherapy in head and neck cancer via ferroptosis-immune cascade activation by Fe-Shikonin nanomedicine
S
Y
Z
M
L
Y
B
W
DOI:10.1016/j.colsurfb.2026.115765.png)
Abstract
En 中文
• Fe-Shikonin nanomedicine undergoes tumor microenvironment-responsive disassembly. • Fe²⁺ release amplifies ROS and lipid peroxidation to induce ferroptosis. • Ferroptotic stress triggers ICD and dendritic cell maturation. • Fe-Shikonin enhances CD8⁺ T-cell responses in HNSCC tumors. • scRNA-seq reveals enhanced antigen presentation and T-cell activation.
Keywords:
ferroptosis
immunotherapy
nanomedicine
tumor microenvironment
T-cell activation
Journal
C
IF:
5.6
Papers:
1.4W
Citations:
4.2W
